CASY heads into the back half of summer with an unusual split: short sellers are adding positions at the fastest pace in months, yet options traders are the least defensive they've been all year.
The short interest angle is worth watching here, even if it isn't alarming yet. Short interest climbed to 4.2% of free float — up 7.4% over the past week and 42% higher than a month ago. That's a meaningful acceleration in a name that has historically carried light short positioning. The borrow market remains easy: availability runs at 1,333%, meaning there are roughly thirteen shares available to lend for every one currently borrowed, and cost to borrow is a negligible 0.45%, down 10% on the week. No squeeze dynamics here — this is orderly short-building, not a crowded trade under stress. The ORTEX short score has drifted higher, from 35.4 on June 26 to 37.6 today, but remains well inside neutral territory.
Options positioning tells the opposite story. The put/call ratio has dropped to 0.97 — its lowest reading of the past 52 weeks — running 1.3 standard deviations below its 20-day average of 1.15. A month ago, that ratio was north of 1.35. The shift is sharp and consistent: investors who were hedging defensively through June have rotated into a more constructive options posture just as shorts are adding. The two camps are pulling in different directions, and the tension is the story this week.
The Street leans constructive, though the picture is layered. The consensus sits at Buy, with 12 buy ratings against 7 holds. Around the late-June earnings print, analyst activity split neatly. Bulls lifted targets: BMO Capital upgraded to Outperform, holding its $950 target, while Evercore ISI and Stephens both carried Outperform ratings with targets in the $975 range. Neutral-rated names moved up too — Goldman Sachs raised its target to $795 from $695, and JPMorgan lifted to $975 from $719 — though both maintained cautious ratings. BNP Paribas trimmed its target modestly to $995 from $1,032 while keeping Outperform. The current price of $802 represents a meaningful discount to the bull camp's targets, but the neutral-to-bearish cluster around $795–$850 sits essentially at spot. On valuation, the trailing PE is running at 36x and price-to-book at 6.5x, both drifting higher over the month. EV/EBITDA at 18.9x has been roughly flat. Factor scores flag strong EPS momentum — 98th percentile on 30-day momentum and 96th on 90-day — and the analyst recommendation differential ranks in the 95th percentile, reflecting how much targets moved after the earnings beat. Value, at the low end of the scoring range, remains the sticking point for the skeptics.
The earnings history adds context to the current positioning. The June 9 print saw the stock jump more than 21% in a single session, and the five-day follow-through added a further 15%. The June 24 event — a separate reporting date — saw a 5.7% one-day decline and similar five-day losses. The asymmetry of those reactions illustrates how much earnings-day execution matters for CASY; the next scheduled print is September 3, which gives the market roughly two months to reprice.
Institutional flow shows BlackRock added 740,000 shares as of June 30, pushing its stake to 11.5% — the largest holder by some distance. State Street and Geode both added meaningfully in the same period. On the insider side, the COO sold $2.4 million in shares on July 1, and the Chief Legal Officer sold $1.6 million on June 29, though these follow a series of award grants in mid-June that are a routine feature of executive compensation cycles. The net 90-day insider position is positive, with awards substantially outweighing open-market sales in share terms.
What to watch into September: whether the short-building of the past month continues at its current pace and whether it starts to tighten the borrow market — and, separately, whether the unusually bullish options posture is repriced as the earnings window approaches.
See the live data behind this article on ORTEX.
Open CASY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
